Altimmune (ALT) Return on Equity [ROE] (2011 - 2026)
Altimmune's Return on Equity [ROE] came in at -24.20% for Q2 2026, up 33.61 percentage points from -57.82% a year earlier and up 11.59 percentage points from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Altimmune's Return on Equity [ROE] was -50.57%, up 9.29 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -14.43 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -59.86% in FY2024 (-13.23 pp), -46.63% in FY2023 (-2.55 pp), -44.07% in FY2022 (+1.62 pp) and -45.69% in FY2021 (-9.55 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2020.
- Year-over-year, Return on Equity [ROE] has increased for five consecutive quarters, with an average year-over-year change of +7.80 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2026 (a gain of 33.61 percentage points), and the weakest in Q1 2022 (a drop of 27.59 percentage points).
- Business Quant data shows ALT's Return on Equity [ROE] at -35.80% (Q1 2026), -42.92% (Q4 2025) and -48.37% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Altimmune | 556.20 Mn | 556.20 Mn | - | -24.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.20% |
| Mar 31, 2026 | -35.80% |
| Dec 31, 2025 | -42.92% |
| Sep 30, 2025 | -48.37% |
| Jun 30, 2025 | -57.82% |
| Mar 31, 2025 | -67.93% |
| Dec 31, 2024 | -74.01% |
| Sep 30, 2024 | -72.41% |
| Jun 30, 2024 | -62.28% |
| Mar 31, 2024 | -50.61% |
| Dec 31, 2023 | -51.43% |
| Sep 30, 2023 | -49.42% |
| Jun 30, 2023 | -48.56% |
| Mar 31, 2023 | -48.38% |
| Dec 31, 2022 | -43.47% |
| Sep 30, 2022 | -43.58% |
| Jun 30, 2022 | -51.17% |
| Mar 31, 2022 | -53.00% |
| Dec 31, 2021 | -47.55% |
| Sep 30, 2021 | -37.21% |
API Access
Altimmune Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();